中國國家文化產業(00745.HK)完成配售9814.41萬股 淨籌約630萬港元
格隆匯 8 月 19日丨中國國家文化產業(00745.HK)發佈公告,配售協議的所有條件均已達成,而配售事項已於2020年8月4日完成。配售代理已按配售價每股0.065港元成功向不少於六名承配人配售合共9814.41萬股配售股份,相當於公司緊隨配售事項完成後經配發及發行配售股份擴大後已發行股本的約16.67%。
配售事項的所得款項淨額為約630萬港元。公司擬將有關所得款項淨額用作集團一般營運資金及改善集團的現金狀況,其將有助於建立及增強集團現有及未來業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.